Ultragenyx Pharmaceutical Inc. develops and commercializes therapies for rare and ultra-rare genetic diseases, offering approved biologics and gene therapies for conditions with high unmet medical need.

Ultragenyx Logo

Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.

About Ultragenyx

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the identification, development, and commercialization of novel therapies for rare and ultra-rare genetic diseases. Its portfolio includes approved biologic products such as Crysvita, Mepsevii, Dojolvi, and Evkeeza, targeting conditions like X-linked hypophosphatemia, Mucopolysaccharidosis VII, long-chain fatty acid oxidation disorders, and homozygous familial hypercholesterolemia. The company also has a robust pipeline of clinical candidates addressing additional rare genetic disorders, including gene therapies and monoclonal antibodies. Ultragenyx collaborates with academic and industry partners to advance treatments for patients globally and is headquartered in Novato, California.

Address

60 Leveroni Court,
Novato, 94949
United States

Year founded

2011

Number of employees

1,000-2,000

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Add Ultragenyx logo and brand data to your app or website

Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.

<img src="https://img.logokit.com/ultragenyx.com" />

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos